Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib
Posted On Monday, August 25, 2025
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market
Posted On Monday, August 25, 2025
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
Posted On Monday, August 25, 2025
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
Posted On Monday, August 25, 2025
4DMT to Participate in Upcoming Investor Conferences
Posted On Monday, August 25, 2025
Arnatar Therapeutics Emerges from Stealth and Announces Receipt of FDA Orphan Drug and Rare Pediatric Disease Designations for ART4
Posted On Monday, August 25, 2025
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Posted On Monday, August 25, 2025
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
Posted On Monday, August 25, 2025
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
Posted On Monday, August 25, 2025
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector
Posted On Sunday, August 24, 2025
Celularity Receives Nasdaq Notice Regarding Form 10-Q
Posted On Friday, August 22, 2025
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Posted On Friday, August 22, 2025
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
Posted On Friday, August 22, 2025
Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
Posted On Friday, August 22, 2025
Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions
Posted On Friday, August 22, 2025
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Posted On Friday, August 22, 2025
CrazyBulk Supplements Bulking Stacks 2025: Crazy Bulk Launch “Safest Legal Steroid Alternatives” for Muscle Growth & Strength for Over 50's
Posted On Friday, August 22, 2025
Highsman and Illicit Partner to Bring HIT STICKS to Missouri with Exclusive Launch Weekend
Posted On Friday, August 22, 2025
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
Posted On Friday, August 22, 2025
Repligen Corporation to Present at Upcoming September Conferences
Posted On Friday, August 22, 2025
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors
Posted On Friday, August 22, 2025
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
Posted On Thursday, August 21, 2025
BioSyent Releases Financial Results for Q2 and H1 2025
Posted On Thursday, August 21, 2025
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
Posted On Thursday, August 21, 2025
BioSyent Declares Third Quarter 2025 Dividend
Posted On Thursday, August 21, 2025

Print